Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib

被引：63

作者：

Rocha, JL ^{[1
]}

Fernández-Alonso, L

机构：

[1] Hosp Univ Virgen del Rocio, Serv Nefrol, Seville 41013, Spain

[2] Hosp Univ Virgen del Rocio, Serv Anat Patol, Seville 41013, Spain

来源：

LANCET | 2001年 / 357卷 / 9272期

关键词：

D O I：

10.1016/S0140-6736(00)05083-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The nephrotoxic effect of COX-2 selective inhibitors has not yet been established. We report a case of reversible acute renal failure due to acute tubulointerstitial nephritis, confirmed by histology of a renal biopsy sample, associated with taking rofecoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor.

引用

页码：1946 / 1947

页数：2

共 5 条

[1]

Brater D. Craig, 1999, American Journal of Medicine, V107, p65S

[2]

Goldstein JL, 2000, J RHEUMATOL, V27, P25

[3] The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19087 patients in general practice in England: cohort study [J].

Martin, RM ;

Biswas, P ;

Mann, RD .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (01) :35-42

[4] Are selective COX-2 inhibitors nephrotoxic? [J].

Perazella, MA ;

Eras, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) :937-940

[5] The clinical spectrum of tubulointerstitial nephritis [J].

Rastegar, A ;

Kashgarian, M .

KIDNEY INTERNATIONAL, 1998, 54 (02) :313-327

← 1 →